Bixiye
QP80-20 MHCP Pharmacy Benefit Update - AvsolaTM, Ilaris® and PerserisTM
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2451 - 2460 ee natiijooyinka 3289
Bixiye
QP78-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa®
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
QP77-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
QP82-20 Commercial Pharmacy Benefit Exclusion for Amzeeq™ (minocycline) foam, brimonidine ophthalmic solution 0.15% and ProAir® (albuterol sulfate) HFA
Taariikhda barnaamijka Dhaqangalayso Agosto 26, 2020
Bixiye
2020 September Provider Press
Taariikhda barnaamijka Dhaqangalayso Agosto 19, 2020
Bixiye
QP76-20 Outlier Outpatient Therapy Management Program
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020